Fonte: Clinical Rheumatology. Unidade: FMRP
Assuntos: ARTRITE REUMATOIDE, DOENÇAS REUMÁTICAS, FÁRMACOS ANTIRREUMÁTICOS, ESPONDILITE ANQUILOSANTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAFÁ, Bárbara P. et al. Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: analysis from BIOBADABRASIL. Clinical Rheumatology, v. 34, n. 5, p. 921-927, 2015Tradução . . Disponível em: https://doi.org/10.1007/s10067-015-2929-7. Acesso em: 07 out. 2024.APA
Fafá, B. P., Louzada Júnior, P., Titton, D. C., Zandonade, E., Ranza, R., Laurindo, I., et al. (2015). Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: analysis from BIOBADABRASIL. Clinical Rheumatology, 34( 5), 921-927. doi:10.1007/s10067-015-2929-7NLM
Fafá BP, Louzada Júnior P, Titton DC, Zandonade E, Ranza R, Laurindo I, Peçanha P, Ranzolin A, Hayata AL, Duarte A, Silveira IG, Costa I, Macieira JC, Guedes-Barbosa LS, Bertolo MB, Sauma MFL da C, Silva MBG, Freire M, Scheinberg MA, Fernandes V, Bianchi W, Miranda JRS, Pinheiro GRC, Carvalho HMS, Brenol CV, Pereira IA, Castro GRW de, Morais JCB de, Oliveira SKF, Abreu MM de, Toledo RA, Pinheiro MM, Vieira WP, Valim V. Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: analysis from BIOBADABRASIL [Internet]. Clinical Rheumatology. 2015 ; 34( 5): 921-927.[citado 2024 out. 07 ] Available from: https://doi.org/10.1007/s10067-015-2929-7Vancouver
Fafá BP, Louzada Júnior P, Titton DC, Zandonade E, Ranza R, Laurindo I, Peçanha P, Ranzolin A, Hayata AL, Duarte A, Silveira IG, Costa I, Macieira JC, Guedes-Barbosa LS, Bertolo MB, Sauma MFL da C, Silva MBG, Freire M, Scheinberg MA, Fernandes V, Bianchi W, Miranda JRS, Pinheiro GRC, Carvalho HMS, Brenol CV, Pereira IA, Castro GRW de, Morais JCB de, Oliveira SKF, Abreu MM de, Toledo RA, Pinheiro MM, Vieira WP, Valim V. Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: analysis from BIOBADABRASIL [Internet]. Clinical Rheumatology. 2015 ; 34( 5): 921-927.[citado 2024 out. 07 ] Available from: https://doi.org/10.1007/s10067-015-2929-7
